These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
494 related articles for article (PubMed ID: 18725050)
21. The PK/PD index (CMAX/MIC) for ciprofloxacin in patients with cystic fibrosis. Szałek E; Kamińska A; Gozdzik-Spychalska J; Grześkowiak E; Batura-Gabryel H Acta Pol Pharm; 2011; 68(5):777-83. PubMed ID: 21928725 [TBL] [Abstract][Full Text] [Related]
22. Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill intensive care unit patients. Dong H; Wang X; Dong Y; Lei J; Li H; You H; Wang M; Xing J; Sun J; Zhu H Int J Antimicrob Agents; 2011 Oct; 38(4):296-300. PubMed ID: 21741222 [TBL] [Abstract][Full Text] [Related]
23. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration? Roberts JA; Roberts MS; Robertson TA; Dalley AJ; Lipman J Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of a once-daily treatment using ciprofloxacin in an extended-release dosage form. Schuck EL; Dalhoff A; Stass H; Derendorf H Infection; 2005 Dec; 33 Suppl 2():22-8. PubMed ID: 16518708 [TBL] [Abstract][Full Text] [Related]
25. Enrofloxacin pharmacokinetics in the European cuttlefish, Sepia officinalis, after a single i.v. injection and bath administration. Gore SR; Harms CA; Kukanich B; Forsythe J; Lewbart GA; Papich MG J Vet Pharmacol Ther; 2005 Oct; 28(5):433-9. PubMed ID: 16207305 [TBL] [Abstract][Full Text] [Related]
26. Correlation of pharmacokinetic parameters to efficacy of antibiotics: relationships between serum concentrations, MIC values, and bacterial eradication in patients with gram-negative pneumonia. Schentag JJ Scand J Infect Dis Suppl; 1990; 74():218-34. PubMed ID: 2097710 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic and pharmacodynamic properties of enrofloxacin in southern crested caracaras (Caracara plancus). Waxman S; Prados AP; de Lucas J; San Andres MI; Sassaroli JC; Orozco M; Argibay H; Rodriguez C J Avian Med Surg; 2013 Sep; 27(3):180-6. PubMed ID: 24344508 [TBL] [Abstract][Full Text] [Related]
29. Fluid shifts have no influence on ciprofloxacin pharmacokinetics in intensive care patients with intra-abdominal sepsis. Gous A; Lipman J; Scribante J; Tshukutsoane S; Hon H; Pinder M; Mathivha R; Verhoef L; Stass H Int J Antimicrob Agents; 2005 Jul; 26(1):50-5. PubMed ID: 15955670 [TBL] [Abstract][Full Text] [Related]
30. Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development? Burkhardt O; Lehmann C; Madabushi R; Kumar V; Derendorf H; Welte T J Antimicrob Chemother; 2006 Oct; 58(4):822-9. PubMed ID: 16885180 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic behaviour of enrofloxacin in greater rheas following a single-dose intramuscular administration. de Lucas JJ; Navarro JL; Rubio S; Vignolo PE; Asis VC; González F; Rodríguez C Vet J; 2008 Jan; 175(1):136-8. PubMed ID: 17303451 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of difloxacin after intravenous, intramuscular, and intragastric administration to horses. Fernández-Varón E; Cárceles CM; Marín P; Martos N; Escudero E; Ayala I Am J Vet Res; 2006 Jun; 67(6):1076-81. PubMed ID: 16740105 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calves. Davis JL; Foster DM; Papich MG J Vet Pharmacol Ther; 2007 Dec; 30(6):564-71. PubMed ID: 17991225 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of enrofloxacin in Korean catfish (Silurus asotus). Kim MS; Lim JH; Park BK; Hwang YH; Yun HI J Vet Pharmacol Ther; 2006 Oct; 29(5):397-402. PubMed ID: 16958784 [TBL] [Abstract][Full Text] [Related]
35. Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration. Burkhardt O; Kumar V; Katterwe D; Majcher-Peszynska J; Drewelow B; Derendorf H; Welte T J Antimicrob Chemother; 2007 Feb; 59(2):277-84. PubMed ID: 17185298 [TBL] [Abstract][Full Text] [Related]
36. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration. Olofsson SK; Marcusson LL; Komp Lindgren P; Hughes D; Cars O J Antimicrob Chemother; 2006 Jun; 57(6):1116-21. PubMed ID: 16624874 [TBL] [Abstract][Full Text] [Related]
37. Comparative mutant prevention concentration and mechanism of resistance to veterinary fluoroquinolones in Staphylococcus pseudintermedius. Awji EG; Tassew DD; Lee JS; Lee SJ; Choi MJ; Reza MA; Rhee MH; Kim TH; Park SC Vet Dermatol; 2012 Aug; 23(4):376-80, e68-9. PubMed ID: 22409306 [TBL] [Abstract][Full Text] [Related]
38. Effect of chloroquine on the bioavailability of ciprofloxacin in humans. Ilo CE; Ilondu NA; Okwoli N; Brown SA; Elo-Ilo JC; Agbasi PU; Orisakwe OE Am J Ther; 2006; 13(5):432-5. PubMed ID: 16988539 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and pharmacodynamics of a novel extended-release ciprofloxacin in healthy volunteers. Washington CB; Hou SY; Campanella C; Hughes N; Brown S; Berner B J Clin Pharmacol; 2005 Nov; 45(11):1236-44. PubMed ID: 16239356 [TBL] [Abstract][Full Text] [Related]
40. Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics. Ulldemolins M; Roberts JA; Wallis SC; Rello J; Lipman J J Antimicrob Chemother; 2010 Aug; 65(8):1771-8. PubMed ID: 20530507 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]